Managing Disruptive Behavior in Healthcare Professionals

Presented By PHILIP HEMPHILL, PhD

Provided by RiverMend Health Institute

Scroll to the Bottom of this Information to Begin this Course

Release date: October 27, 2016

Valid through: October 27, 2019

Topic: Treatment, Recovery, Addicted Professionals, Disruptive Professionals

Media: Internet

Estimated Time to Complete Activity: 60 minutes

Target Audience

This CE activity is intended for physicians, psychiatrists, physician assistants, psychologists, and allied mental health advocates.

Program Overview

A growing and converging body of literature is establishing the empirical association between disruptive behavior and safety/quality. Leape and Fromme (2006) based upon a review of studies estimate the prevalence of disruptive behavior to range between 3-5%. Rosenstein and O’Daniel (2008) recommend three broad approaches to address disruptive behavior including prevention, addressing it when it occurs in real-time, and dealing with it after a particular incident or series of incidents occur. The focus of this session will be how to deal with disruptive behavior after it takes place. This focus does not dismiss the importance of prevention and other efforts. Yet, it will describe the individuals responsible for disruptive behavior and the numerous direct and indirect costs associated with their behavior. The assessment, treatment, and monitoring of these individuals allows a reallocation of resources and a redirecting of time, attention, and energy of administrators, providers, HR professionals, risk managers, and legal counsel.

Learning Objectives

Upon completion of this activity, participants should be better able to: 

  1. Identify warning signs of professionals who may be at increased risk for disruptive workplace behavior.
  2. Gain knowledge of dimensions of assessment, treatment, and monitoring for success in the reintegration process.
  3. Obtain measurable data to support a 360 degree monitoring tool.

Continuing Education

ADACGBA, Approved Continuing Education Provider

RiverMend Health Centers, a RiverMend Health LLC entity, maintains responsibility for this program and its content. RiverMend Health LLC is a ADACGBA Approved Continuing Education Provider and may offer ADACBGA approved hours for events that meet ADACBGA requirements. Provider #15-55-03-916

ADACBGA Continuing Education Units Awarded: 1.0

NAADAC, The Association for Addiction Professionals

RiverMend Health Institute is a NAADAC Approved Continuing Education Provider and may offer NAADAC- National Certification Commission approved hours for events that meet NAADAC requirements. Provider # 146437.

NAADAC Continuing Education Units awarded: 1.0

NBCC, National Board of Certified Counselors

RiverMend Health is an NBCC-Approved Continuing Education Provider (ACEP™) and may offer NBCC approved clock hours for events that meet NBCC requirements. The ACEP solely is responsible for all aspects of the program. Provider #6781.

NBCC CE credit Awarded: 1.0

CBBS, California Board of Behavioral Sciences

This course meets the qualifications for continuing education credit for MFTs, LPCCs, LEPs and/or LCSWs as required by the California Board of Behavioral Sciences. RiverMend Health Institute Provider #4688.

CBBS CE credit awarded: 1.0

CDR, Commission on Dietetic Registration

RiverMend Health Institute is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians registered (CDR). Registered dietitians (RDs) and dietetic technicians registered (DTRs) will receive continuing professional education units (CPEUs) for the completion of this program. CDR Provider #R1656.

CDR CPEU awarded: 1.0

Faculty

PHILIP HEMPHIL, PhD

PHILIP HEMPHILL, PhD

Dr. Hemphill is the Chief Clinical Officer of Lakeview Health a premier addiction treatment facility where he is responsible for the planning, organizing, implementing and directing all of the company's behavioral health and other clinical services with cost effective methodologies while ensuring clinical efficacy. As a member of the Executive Leadership, he works collaboratively with medical staff leaders in decision making structures and processes. He is the lead person for developing and implementing plans for provision of patient care services, policies, and procedures that delineate how patient care needs are assessed and delivered by the company. He has presented papers and workshops at national conferences and published articles in the field of trauma, personality disorders, and addictions during the past 25 years.

Dr. Hemphill has been an adjunct professor at Tulane University School of Social Work for the past 17 years and Assistant Clinical Professor at LSU Health Sciences Center, Department of Psychiatry for the past 15 years and recently joined the adjunct faculty at Jacksonville University. He received his master and doctoral degrees from Tulane University.

Disclosures of Conflicts of Interest

PHILIP HEMPHILL, PhD
  • Paid employee, Lakeview Health

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.

Hardware and Software Requirements

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. You will need a PDF viewer such as Adobe Reader to view PDF files.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.